Wormiza 222mg contains fenbendazole, a benzimidazole-class antiparasitic compound. Fenbendazole is primarily used in veterinary medicine to treat and control certain susceptible parasitic worms in animals.
The appropriate use of fenbendazole depends on the animal species, parasite involved, product formulation, and approved labeling. FDA-approved fenbendazole products are available for specific animal uses, including certain intestinal, stomach, and lungworm infections.
Wormiza 222mg should therefore be considered according to its product labeling and intended veterinary use rather than being described as a general medicine for human parasitic infections.
The active ingredient in Wormiza 222mg is fenbendazole 222mg. The compound works against susceptible parasites by interfering with processes that are necessary for their survival. The exact effect and approved indications depend on the animal species and formulation.
The tablet may also contain inactive ingredients such as binders, fillers, stabilizers, or other formulation components. The complete inactive-ingredient list should be checked on the manufacturer's packaging or product documentation.
Fenbendazole is used in veterinary medicine for certain parasitic worm infections. Depending on the product and animal species, approved indications may include parasites such as:
A veterinarian should determine which treatment is appropriate based on the animal, suspected parasite, diagnosis, and product label.
Fenbendazole is a benzimidazole antiparasitic that interferes with important biological processes inside susceptible parasites.
It can disrupt microtubule production and nutrient-related processes, which affects the parasite's ability to survive and maintain normal cellular function. FDA documentation describes fenbendazole as interfering with glucose uptake, protein secretion, and microtubule production in susceptible parasites.
The response to treatment depends on the parasite, animal species, dosage, and duration of therapy. It is therefore not appropriate to assume that every parasite will respond in the same way.
The correct dose of fenbendazole depends on the animal species, body weight, parasite, product formulation, and approved indication.
For this reason, Wormiza 222mg should be administered only according to the applicable product label or veterinary instructions. Do not copy a dosage intended for one animal species to another.
Do not increase the amount, extend the treatment period, or change the dosing schedule without professional veterinary guidance.
FDA-approved fenbendazole products have different dosing instructions depending on the animal and indication. For example, one FDA-described canine product uses a weight-based regimen, while newer cattle and goat products have different labeled directions.
Other Wormiza strengths may include:
Availability and formulations can vary, so check the individual product information before use.
Fenbendazole should be used according to the instructions for the intended animal and product.
FDA advises that legally marketed animal drugs should be identifiable through appropriate approval or indexing information and recommends checking the product label and FDA databases.
Fenbendazole is generally considered safe when used at the labeled dose, duration, and indication for the appropriate animal. However, adverse reactions can occur.
Possible reactions may include:
More serious problems have also been reported with prolonged or extra-label use. FDA has reported cases of bone marrow hypoplasia and pancytopenia in dogs receiving fenbendazole for longer than the labeled duration.
If an animal develops severe or unusual symptoms following treatment, contact a veterinarian promptly.
The possibility of an interaction depends on the animal, medicine, dose, and treatment circumstances.
Before using fenbendazole together with another medicine, tell the veterinarian about all prescription medicines, non-prescription products, supplements, and other treatments the animal is receiving.
Do not assume that fenbendazole can safely be combined with another antiparasitic simply because both medicines are used for worms.
Fenbendazole, ivermectin, albendazole, mebendazole, praziquantel, and other antiparasitic medicines work differently and have different approved uses.
The right treatment depends on the parasite and the animal being treated. For example, fenbendazole is approved for specific parasite indications in certain animals, while other antiparasitic medicines may be preferred for different parasites.
Wormiza 222mg should not be described as a general human deworming medicine without appropriate regulatory approval and clinical evidence.
FDA information identifies fenbendazole as a veterinary drug and lists approved uses for particular animal species. Some veterinary fenbendazole labeling also includes warnings against human use.
If a person believes they have a parasitic infection, they should consult a qualified healthcare professional for diagnosis and treatment with a medicine approved for human use.
In general, veterinary medicines should be:
Always follow the manufacturer's storage requirements rather than relying on a general temperature recommendation.
Before obtaining fenbendazole, verify the product name, manufacturer, strength, intended species, labeling, and applicable regulatory information.
For veterinary use, prescription or veterinary oversight may be required depending on the product and jurisdiction. FDA notes that prescription animal drugs can only be dispensed on the lawful order of a licensed veterinarian.
For suspected human parasitic infections, seek medical advice rather than purchasing or using a veterinary fenbendazole other product.
Wormiza 222mg contains fenbendazole, a benzimidazole antiparasitic compound used primarily in veterinary medicine. It works against susceptible parasites by interfering with biological processes that are essential for parasite survival.
The appropriate dose, duration, and indication depend on the animal species, parasite, and specific formulation. Because veterinary fenbendazole products are not automatically appropriate for humans, they should not be marketed as a general human deworming treatment.
Use fenbendazole only according to the applicable product labeling and professional veterinary guidance.
Depending on the product and animal species, fenbendazole may be approved for certain roundworms, hookworms, whipworms, strongyles, ascarids, stomach worms, intestinal worms, or lungworms. The exact approved indications depend on the product label.
The dose depends on the animal species, body weight, parasite, formulation, and approved indication. Follow the specific product label or veterinarian's instructions.
Veterinary fenbendazole products should not be used by humans. Anyone with suspected parasitic infection should consult a healthcare professional about appropriate human treatment.
Do not intentionally exceed the recommended dose. If an animal receives more than directed or develops unusual symptoms, contact a veterinarian for advice.
Potential interactions depend on the specific animal and medicines involved. Provide the veterinarian with a complete list of current medicines and supplements before treatment.
| Pack Size | Price |
|---|---|
| 100 Tablet/s | $35.00 |
| 200 Tablet/s | $60.00 |
| 300 Tablet/s | $82.00 |
Medical Disclaimer: The information on this site is for educational purposes only. Consult a licensed healthcare professional before starting, stopping, or changing any medication.
Reviews
There are no reviews yet.